Press release
Investigation announced for Investors in RenovaCare, Inc. (OTC: RCAR)

An investigation for investors in RenovaCare, Inc. (OTC: RCAR) shares over potential securities laws violations by RenovaCare, Inc
Investors who purchased shares of RenovaCare, Inc. (OTC: RCAR), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether a series of statements by RenovaCare, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
Roseland, NJ based RenovaCare, Inc., a development-stage biotech and medical device company, focuses on the research, development, and commercialization of autologous cellular therapies for use in medical and aesthetic applications.
On May 28, 2021, the United States Securities and Exchange Commission (“SEC”) published a litigation release indicating the RenovaCare, Inc. was being charged with securities fraud. Specifically, the complaint referenced in the litigation release, filed in federal court in the Southern District of New York, alleges that in July 2017, Harmel S. Rayat, RenovaCare's controlling shareholder, arranged, and caused RenovaCare to pay for, a promotional campaign designed to increase the company's stock price." The complaint alleges that "Rayat was closely involved in directing the promotion and editing promotional materials, and arranged to funnel payments to the publisher through consultants to conceal RenovaCare's involvement in the campaign" and according to the complaint, "in January 2018, OTC Markets Group, Inc. requested RenovaCare issue a press release to explain its relationship to the promotion." Finally, the complaint alleges that "Rayat and RenovaCare then drafted and issued a press release and a Form 8-K that contained material misrepresentations and omissions denying Rayat's and the company's involvement in the promotion" and charges Rayat and RenovaCare with "violating the antifraud provisions of Section 10(b) of the Securities Exchange Act of 1934 and Rule 10b-5 thereunder, and also charges Rayat with aiding and abetting the company's violations of those provisions." The complaint also charges RenovaCare with violating the reporting provisions of Exchange Act Section 15(d) and Rules 15d-11 and 12b-20 thereunder.
Shares of RenovaCare, Inc. (OTC: RCAR) declined to as low as $1.45 per share on June 2, 2021.
Those who purchased shares of RenovaCare, Inc. (OTC: RCAR) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investigation announced for Investors in RenovaCare, Inc. (OTC: RCAR) here
News-ID: 2300000 • Views: …
More Releases from Shareholders Foundation

Biohaven Ltd. (NYSE: BHVN) Investor Alert: Deadline in Lawsuit on September 12, …
A deadline is coming up on September 12, 2025in the lawsuit filed for certain investors of Biohaven Ltd. (NYSE: BHVN) over alleged securities laws violations by Biohaven Ltd.
Investors who purchased shares of Biohaven Ltd. (NYSE: BHVN) have certain options and there are strict and short deadlines running. Deadline: September 12, 2025. NYSE: BHVN stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According to the…

Investigation announced for Long-Term Investors in shares of West Pharmaceutical …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of West Pharmaceutical Services, Inc..
Investors who are current long term investors in West Pharmaceutical Services, Inc. (NYSE: WST) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in (NYSE: WST stocks follows a lawsuit filed…

Investigation announced for Long-Term Investors in Open Lending Corporation (NAS …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Open Lending Corporation.
Investors who are current long term investors in Open Lending Corporation (NASDAQ: LPRO) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: LPRO stocks follows a lawsuit filed against Open…

Investigation announced for Long-Term Investors in shares in BigBear.ai Holdings …
An investigation on behalf of current long-term investors in shares of BigBear.ai Holdings, Inc. (NYSE: BBAI) concerning potential breaches of fiduciary duties by certain directors and officers of BigBear.ai Holdings, Inc. was announced.
Investors who are current long term investors in BigBear.ai Holdings, Inc. (NYSE: BBAI) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm…
More Releases for RenovaCare
Burns Market Growth to Accelerate in Forecast Period (2024-2034), DelveInsight A …
DelveInsight's "Burns Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Burns, historical and forecasted epidemiology as well as the Burns market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Burns market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Burns Market Forecast
https://www.delveinsight.com/sample-request/burns-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the key facts of the Burns Market Report:…
Burns Market is Expected to Expand at a Healthy Growth Rate During the Forecast …
The Key Burns Companies in the market include - Kerecis, Mallinckrodt Pharmaceuticals, Skingenix, RenovaCare, CUTISS AG, Argle Therapeutics, Medline Industries, Amryt Pharma, MediWound Ltd, MediWound Ltd, Cumberland Pharmaceuticals, Pfizer, Kuros Biosurgery AG, Bayer, and others.
DelveInsight's "Burns Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Burns, historical and forecasted epidemiology as well as the Burns market trends in the United States, EU4 (Germany, Spain, Italy, France)…
Polymers Drug Delivery Market Size, Scope And Growth Analysis Forecast 2028 | Ac …
Polymers Drug Delivery Market is an vital source of information which gives recent and upcoming technical and financial details about the industry. All composed market statistics data is verified and legal by industry specialists for readers and end users. It develops easy to analyze the actions of key players and their effects on sales, imports-exports, revenues and CAGR values with this credible marketing report. Furthermore, companies in the report are…
Investigation announced for Long-Term Investors in shares of RenovaCare, Inc. (O …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of RenovaCare, Inc..
Investors who are current long term investors in RenovaCare, Inc. (OTC: RCAR) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in OTC: RCAR stocks follows a lawsuit filed against RenovaCare, Inc. over…
OTC: RCAR Investor Alert: Deadline on September 14, 2021 in Lawsuit against Reno …
A deadline is coming up on September 14, 2021 in the lawsuit filed for certain investors of RenovaCare, Inc. (OTC: RCAR) over alleged securities laws violations by RenovaCare, Inc.
Investors who purchased shares of RenovaCare, Inc. (OTC: RCAR) have certain options and there are strict and short deadlines running. Deadline: September 14, 2021. OTC: RCAR stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According to the…
Lawsuit filed for Investors in shares of RenovaCare, Inc. (OTC: RCAR)
An investor, who purchased shares of RenovaCare, Inc. (OTC: RCAR), filed a lawsuit over alleged violations of Federal Securities Laws by RenovaCare, Inc..
Investors who purchased shares of RenovaCare, Inc. (OTC: RCAR) have certain options and for certain investors are short and strict deadlines running. Deadline: September 14, 2021. OTC: RCAR investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
Roseland, NJ based RenovaCare, Inc., a development-stage…